Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$73.9M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| May 21 | MRNA | Moderna, Inc. | MEXER | 9,263 | $19.15 | $177.4K | +236.1% | Open the original filing on SEC.gov |
| May 6 | MRNA | Moderna, Inc. | AGRANT◆ | 12,908 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 2.1M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 2.5M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 2.1M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 3M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 843,881 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 1.5M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 17M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV◆ | 18.5M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | PBUY | 1.6M | $16.00 | $25M | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | PBUY | 1.6M | $16.00 | $25M | +56.3% | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | PBUY | 1.6M | $16.00 | $25M | +11.4% | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV | 2.8M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV | 2.8M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV | 987,491 | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV | 13.7M | — | — | — | Open the original filing on SEC.gov |
| Mar 2 | GENB | Generate Biomedicines,… | CCONV | 12.7M | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | GENB | Generate Biomedicines,… | AGRANT◆ | 29,561 | — | — | — | Open the original filing on SEC.gov |
| Dec 11, 2025 | MRNA | Moderna, Inc. | MEXER◆ | 23,853 | — | — | — | Open the original filing on SEC.gov |
| Dec 11, 2025 | MRNA | Moderna, Inc. | SSELL | 23,853 | $29.49 | $703.3K | -85.9% | Open the original filing on SEC.gov |
| Dec 11, 2025 | MRNA | Moderna, Inc. | MEXER | 23,853 | $10.90 | $260K | +607.9% | Open the original filing on SEC.gov |
| Apr 30, 2025 | MRNA | Moderna, Inc. | AGRANT◆ | 25,512 | — | — | — | Open the original filing on SEC.gov |